Targeting Aβ and tau in Alzheimer's disease, an early interim report
- 27 August 2009
- journal article
- review article
- Published by Elsevier in Experimental Neurology
- Vol. 223 (2) , 252-266
- https://doi.org/10.1016/j.expneurol.2009.07.035
Abstract
No abstract availableThis publication has 177 references indexed in Scilit:
- The Aβ Hypothesis: Leading Us to Rationally-Designed Therapeutic Strategies for the Treatment or Prevention of Alzheimer DiseaseBrain Pathology, 2006
- 1,026 Experimental treatments in acute strokeAnnals of Neurology, 2006
- Lithium Chloride Increases the Production of Amyloid-β Peptide Independently from Its Inhibition of Glycogen Synthase Kinase 3Journal of Biological Chemistry, 2005
- Tau Suppression in a Neurodegenerative Mouse Model Improves Memory FunctionScience, 2005
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐BAnnals of Neurology, 2004
- Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance imagesThe Lancet, 2001
- Constitutive overactivation of protein kinase C in guinea pig brain increases α‐secretory APP processing without decreasing β‐amyloid generationEuropean Journal of Neuroscience, 2000
- Accelerated filament formation from tau protein with specific FTDP‐17 missense mutationsFEBS Letters, 1999
- The carboxy terminus of the .beta. amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's diseaseBiochemistry, 1993
- The Alzheimer‐like phosphorylation of tau protein reduces microtubule binding and involves Ser‐Pro and Thr‐Pro motifsFEBS Letters, 1992